The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling (Human Molecular Genetics (2007) 16:1 (92-106) DOI: 10.1093/hmg/ddl444);The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling

Human Molecular Genetics

Volumn 16, Issue 1, 2007, Pages 92-106

  Bitoun, Emmanuelle ^a   Oliver, Peter L ^a   Davies, Kay E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; ELONGATION FACTOR B; ELONGATION FACTOR B KINASE; FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE H3; LUCIFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEAR PROTEIN; PROTEIN AF10; PROTEIN AF4; PROTEIN AF9; PROTEIN DOT1; PROTEIN ENL; PROTEIN KINASE; REGULATOR PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATAXIA; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; FRAGILE X SYNDROME; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; MENTAL DEFICIENCY; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 33846522525     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddad167     Document Type: Erratum

References (84)

1. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C.M. and Canaani, E. (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell, 71, 701-708.
2. Mitelman, F. and Heim, S. (1992) Quantitative acute leukemia cytogenetics. Genes Chrom. Cancer, 5, 57-66.
3. Hess, J.L. (2004) MLL: A histone methyltransferase disrupted in leukemia. Trends Mol. Med., 10, 500-507.
4. von Bergh, A.R., Beverloo, H.B., Rombout, P., van Wering, E.R., van Weel, M.H., Beverstock, G.C., Kluin, P.M., Slater, R.M. and Schuuring, E. (2002) LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chrom. Cancer, 35, 92-96.
5. Taki, T., Kano, H., Taniwaki, M., Sako, M., Yanagisawa, M. and Hayashi, Y. (1999) AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl Acad. Sci. USA, 96, 14535-14540.
6. Chakrabarti, L., Knight, S.J., Flannery, A.V. and Davies, K.E. (1996) A candidate gene for mild mental handicap at the FRAXE fragile site. Hum. Mol. Genet., 5, 275-282.
7. Nilson, I., Reichel, M., Ennas, M.G., Greim, R., Knorr, C., Siegler, G., Greil, J., Fey, G.H. and Marschalek, R. (1997) Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br. J. Haematol., 98, 157-169.
8. Prasad, R., Yano, T., Sorio, C., Nakamura, T., Rallapalli, R., Gu, Y., Leshkowitz, D., Croce, C.M. and Canaani, E. (1995) Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl Acad. Sci. USA, 92, 12160-12164.
9. Ma, C. and Staudt, L.M. (1996) LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. Blood, 87, 734-745.
10. Baskaran, K., Erfurth, F., Taborn, G., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Iannaccone, P.M. and Domer, P.H. (1997) Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4. Oncogene, 15, 1967-1978.
11. Hillman, M.A. and Gecz, J. (2001) Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J. Hum. Genet., 46, 251-259.
12. Estable, M.C., Naghavi, M.H., Kato, H., Xiao, H., Qin, J., Vahlne, A. and Roeder, R.G. (2002) MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J. Biomed. Sci., 9, 234-245.
13. Bursen, A., Moritz, S., Gaussmann, A., Dingermann, T. and Marschalek, R. (2004) Interaction of AF4 wild-type and AF4-MLL fusion protein with SIAH proteins: Indication for t(4;11) pathobiology? Oncogene, 23, 6237-6249.
14. Oliver, P.L., Bitoun, E., Clark, J., Jones, E.L. and Davies, K.E. (2004) Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc. Natl Acad. Sci. USA, 101, 14901-14906.
15. Ciechanover, A., Orian, A. and Schwartz, A.L. (2000) Ubiquitin-mediated proteolysis: Biological regulation via destruction. Bioessays, 22, 442-451.
16. Isnard, P., Core, N., Naquet, P. and Djabali, M. (2000) Altered lymphoid development in mice deficient for the mAF4 proto-oncogene. Blood, 96, 705-710.
17. Isaacs, A.M., Oliver, P.L., Jones, E.L., Jeans, A., Potter, A., Hovik, B.H., Nolan, P.M., Vizor, L., Glenister, P., Simon, A.K. et al. (2003) A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J. Neurosci., 23, 1631-1637.
18. Bitoun, E. and Davies, K.E. (2005) The robotic mouse: Unravelling the function of AF4 in the cerebellum. Cerebellum, 4, 1-11.
19. Naar, A.M., Lemon, B.D. and Tjian, R. (2001) Transcriptional coactivator complexes. Annu. Rev. Biochem., 70, 475-501.
20. Thirman, M.J., Levitan, D.A., Kobayashi, H., Simon, M.C. and Rowley, J.D. (1994) Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukaemia. Proc. Natl Acad. Sci. USA, 91, 12110-12114.
21. Shilatifard, A., Lane, W.S., Jackson, K.W., Conaway, R.C. and Conaway, J.W. (1996) An RNA polymerase II elongation factor encoded by the human ELL gene. Science, 271, 1873-71876.
22. Conaway, J.W., Shilatifard, A., Dvir, A. and Conaway, R.C. (2000) Control of elongation by RNA polymerase II. Trends Biochem. Sci., 25, 375-380.
23. Peng, J., Zhu, Y., Milton, J.T. and Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev., 12, 755-762.
24. Gerber, M. and Shilatifard, A. (2003) Transcriptional elongation by RNA polymerase II and histone methylation. J. Biol. Chem., 278, 26303-26306.
25. Martin, C. and Zhang, Y. (2005) The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol., 6, 838-849.
26. Hampsey, M. and Reinberg, D. (2003) Tails of intrigue: Phosphorylation of RNA polymerase II mediates histone methylation. Cell, 113, 429-432.
27. Krogan, N.J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D.P., Beattie, B.K., Emili, A., Boone, C. et al. (2003) Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol. Cell Biol., 23, 4207-4218.
28. Li, B., Howe, L., Anderson, S., Yates, J.R. and Workman, J.L. (2003) The Set2 histone methyltransferase functions through the phosphorylated carboxyterminal domain of RNA polymerase II. J. Biol. Chem., 277, 8897-8903.
29. Xiao, T., Hall, H., Kizer, K.O., Shibata, Y., Hall, M.C., Borchers, C.H. and Strahl, B.D. (2003) Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev., 17, 654-663.
30. Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V.M., Su, L., Xu, G. and Zhang, Y. (2005) hDOT1L links histone methylation to leukemogenesis. Cell, 121, 167-178.
31. Shibuya, N., Taki, T., Mugishima, H., Chin, M., Tsuchida, M., Sako, M., Kawa, K., Ishii, E., Miura, I., Yanagisawa, M. et al. (2001) t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: Specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines. Genes Chrom. Cancer, 32, 1-10.
32. DiMartino, J.F., Ayton, P.M., Chen, E.H., Naftzger, C.C., Young, B.D. and Cleary, M.L. (2002) The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood, 99, 3780-3785.
33. Iida, S., Seto, M., Yamamoto, K., Komatsu, H., Tojo, A., Asano, S., Kamada, N., Ariyoshi, Y., Takahashi, T. and Ueda, R. (1993) MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene, 8, 3085-3092.
34. Tkachuk, D.C., Kohler, S. and Cleary, M.L. (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell, 71, 691-700.
35. Rubnitz, J.E., Morrissey, J., Savage, P.A. and Cleary, M.L. (1994) ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood, 84, 1747-1752.
36. Nakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R.P., Lange, B., Crist, W.M., Nowell, P.C. et al. (1993) Genes on chromosomes 4, 9 and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl Acad. Sci. USA, 90, 4631-4635.
37. Erfurth, F., Hemenway, C.S., de Erkenez, A.C. and Domer, P.H. (2004) MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia, 18, 92-102.
38. Zeisig, D.T., Bittner, C.B., Zeisig, B.B., Garcia-Cuellar, M.P., Hess, J.L. and Slany, R.K. (2005) The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene, 24, 5525-5532.
39. Marshall, N.F., Peng, J., Xie, Z. and Price, D.H. (1996) Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem., 271, 27176-27183.
40. Crews, C.M. (2003) Feeding the machine: Mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins. Curr. Opin. Chem. Biol., 7, 534-539.
41. Isnard, P., Depetris, D., Mattei, M.G., Ferrier, P. and Djabali, M. (1998) cDNA cloning, expression and chromosomal localization of the murine AF-4 gene involved in human leukemia. Mamm. Genome, 9, 1065-1068.
42. Garriga, J., Mayol, X. and Grana, X. (1996) The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem. J., 319, 293-298.
43. Ahn, S.H., Kim, M. and Buratowski, S. (2004) Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Mol. Cell, 13, 67-76.
44. Ni, Z., Schwartz, B.E., Werner, J., Suarez, J.R. and Lis, J.T. (2004) Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol. Cell, 13, 55-65.
45. Yik, J.H., Chen, R., Nishimura, R., Jennings, J.L., Link, A.J. and Zhou, Q. (2003) Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell, 12, 971-982.
46. Michels, A.A., Fraldi, A., Li, Q., Adamson, T.E., Bonnet, F., Nguyen, V.T., Sedore, S.C., Price, J.P., Price, D.H., Lania, L. et al. (2004) Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/ cyclin T) inhibitor. EMBO J., 23, 2608-2619.
47. Byers, S.A., Price, J.P., Cooper, J.J., Li, Q. and Price, D.H. (2005) HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK. J. Biol. Chem., 280, 16360-16367.
48. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B. and Price, D.H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev., 11, 2622-2632.
49. Kanazawa, S., Okamoto, T. and Peterlin, B.M. (2000) Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity, 12, 61-70.
50. Eberhardy, S.R. and Farnham, P.J. (2001) c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem., 276, 48562-48571.
51. Barboric, M., Nissen, R.M., Kanazawa, S., Jabrane-Ferrat, N. and Peterlin, B.M. (2001) NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell, 8, 327-337.
52. Simone, C., Stiegler, P., Bagella, L., Pucci, B., Bellan, C., De Falco, G., De Luca, A., Guanti, G., Puri, P.L. and Giordano, A. (2002) Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene, 21, 4137-4148.
53. Jang, M.K., Mochizuki, K., Zhou, M., Jeong, H.S., Brady, J.N. and Ozato, K. (2005) The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell, 19, 523-534.
54. Yang, Z., Yik, J.H., Chen, R., He, N., Jang, M.K., Ozato, K. and Zhou, Q. (2005) Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell, 19, 535-545.
55. Kong, S.E., Banks, C.A., Shilatifard, A., Conaway, J.W. and Conaway, R.C. (2005) ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc. Natl Acad. Sci. USA, 102, 10094-10098.
56. Gu, Y., McIlwain, K.L., Weeber, E.J., Yamagata, T., Xu, B., Antalffy, B.A., Reyes, C., Yuva-Paylor, L., Armstrong, D., Zoghbi, H. et al. (2002) Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J. Neurosci., 22, 2753-2763.
57. Bernert, G., Nemethova, M., Herrera-Marschitz, M., Cairns, N. and Lubec, G. (1996) Decreased cyclin dependent kinase in brain of patients with Down syndrome. Neurosci. Lett., 216, 68-70.
58. Kitao, Y., Hashimoto, K., Matsuyama, T., Iso, H., Tamatani, T., Hori, O., Stern, D.M., Kano, M., Ozawa, K. and Ogawa, S. (2004) ORP150/HSP12A regulates Purkinje cell survival: A role for endoplasmic reticulum stress in cerebellar development. J. Neurosci., 24, 1486-1496.
59. Moretti, P., Levenson, J.M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J.D. and Zoghbi, H.Y. (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci., 26, 319-327.
60. Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J. and Radulovic, J. (2003) Regulation of contextual fear conditioning by baseline and inducible septo-hippocampal cyclin-dependent kinase 5. Neuropharmacology, 44, 1089-1099.
61. Armstrong, C.L., Krueger-Naug, A.M., Currie, R.W. and Hawkes, R. (2001) Constitutive expression of heat shock protein HSP25 in the central nervous system of the developing and adult mouse. J. Comp. Neurol., 434, 262-274.
62. Ino, H., Ishizuka, T., Chiba, T. and Tatibana, M. (1994) Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems. Brain Res., 661, 196-206.
63. Bagella, L., MacLachlan, T.K., Buono, R.J., Pisano, M.M., Giordano, A. and De Luca, A. (1998) Cloning of murine CDK9/PITALRE and its tissue-specific expression in development. J. Cell Physiol., 177, 206-213.
64. Levenson, J.M. and Sweatt, J.D. (2005) Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci., 6, 108-118.
65. Zhang, W., Xia, X., Reisenauer, M.R., Hemenway, C.S. and Kone, B.C. (2006) Dotla - AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner. J. Biol. Chem., 281, 18059-18068.
66. Nguyen, M.D., Mushynski, W.E. and Julien, J.P. (2002) Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ., 9, 1294-1306.
67. Smith, P.D., O'Hare, M.J. and Park, D.S. (2004) Emerging pathogenic role for cyclin dependent kinases in neurodegeneration. Cell Cycle, 3, 289-291.
68. Zhang, M., Li, J., Chakrabarty, P., Bu, B. and Vincent, I. (2004) Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am. J. Pathol., 165, 843-853.
69. Mattson, M.P. (2003) Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res. Rev., 2, 329-342.
70. Conaway, J.W. and Conaway, R.C. (1999) Transcription elongation and human disease. Annu. Rev. Biochem., 68, 301-319.
71. Pramparo, T., Grosso, S., Messa, J., Zatterale, A., Bonaglia, M.C., Chessa, L., Balestri, P., Rocchi, M., Zuffardi, O. and Giorda, R. (2005) Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor development delay, cerebellar ataxia, and epilepsy. Hum. Genet., 118, 76-81.
72. Chakrabarti, L., Bristulf, J., Foss, G.S. and Davies, K.E. (1998) Expression of the murine homologue of FMR2 in mouse brain and during development. Hum. Mol. Genet., 7, 441-448.
73. Miller, W.J., Skinner, J.A., Foss, G.S. and Davies, K.E. (2000) Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. Eur. J. Neurosci., 12, 381-384.
74. Daum, I. and Ackermann, H. (1995) Cerebellar contributions to cognition. Behav. Brain Res., 67, 201-210.
75. Attwell, P.J., Cooke, S.F. and Yeo, C.H. (2002) Cerebellar function in consolidation of a motor memory. Neuron, 34, 1011-1020.
76. Boyden, E.S., Katoh, A. and Raymond, J.L. (2004) Cerebellum-dependent learning: The role of multiple plasticity mechanisms. Annu. Rev. Neurosci., 27, 581-609.
77. Eguchi, M., Eguchi-Ishimae, M. and Greaves, M. (2005) Molecular pathogenesis of MLL-associated leukemias. Int. J. Hematol., 82, 9-20.
78. So, C.W. and Cleary, M.L. (2003) Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood, 101, 633-639.
79. Ferrando, A.A., Armstrong, S.A., Neuberg, D.S., Sallan, S.E., Silverman, L.B., Korsmeyer, S.J. and Look, A.T. (2003) Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation. Blood, 102, 262-268.
80. Hess, J.L. (2004) Mechanisms of transformation by MLL. Crit. Rev. Eukaryot. Gene Expr., 14, 235-254.
81. Ayton, P.M. and Cleary, M.L. (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev., 17, 2298-2307.
82. Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M.W., van Dongen, J.J., den Boer, M.L. et al. (2006) The MLL recombinome of acute leukemias. Leukemia, 20, 777-784.
83. Milne, T.A., Martin, M.E., Brock, H.W., Slany, R.K. and Hess, J.L. (2005) Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res., 65, 11367-11374.
84. Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C.M. and Canaani, E. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell, 10, 1119-1128.